IVA in 214 limbs. Clinical recurrence rates at 24 months were 4.3%, 7.2%, and 14.7% for
HL&S, RFA and CHIVA, respectively. Ultrasound recurrences were 7.1% for HL&S, 13% for RFA, and 46.7% for
CHIVA. With an 80% power to assess noninferiority, the
study found R